SEEGPHARM SA FDA Approval ANDA 210178

ANDA 210178

SEEGPHARM SA

FDA Drug Application

Application #210178

Application Sponsors

ANDA 210178SEEGPHARM SA

Marketing Status

Prescription001

Application Products

001GEL;TOPICAL5%0DAPSONEDAPSONE

FDA Submissions

UNKNOWN; ORIG1AP2022-03-31STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

SEEGPHARM SA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210178
            [companyName] => SEEGPHARM SA
            [docInserts] => ["",""]
            [products] => [{"drugName":"DAPSONE","activeIngredients":"DAPSONE","strength":"5%","dosageForm":"GEL;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"DAPSONE","submission":"DAPSONE","actionType":"5%","submissionClassification":"GEL;TOPICAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.